Fungi in cystic fibrosis and non-cystic fibrosis bronchiectasis

Seminars in Respiratory and Critical Care Medicine

Volumn 36, Issue 2, 2015, Pages 207-216

  Moss, Richard B ^a  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

allergic bronchopulmonary aspergillosis; allergic bronchopulmonary mycosis; Aspergillus fumigatus; bronchiectasis; cystic fibrosis

Indexed keywords

ALLERGEN; ANTIFUNGAL AGENT; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; AMPHOTERICIN B; IMMUNOGLOBULIN E; TRIAZOLE DERIVATIVE;

ADAPTIVE IMMUNITY; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BRONCHIECTASIS; CANDIDA ALBICANS; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; FUNGAL VIRULENCE; HUMAN; INCIDENCE; INNATE IMMUNITY; LUNG LAVAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHYLLUM COMMUNE; ASPERGILLOSIS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; BLOOD; HYPERSENSITIVITY; MICROBIOLOGY; PATHOGENICITY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; BRONCHIECTASIS; CYSTIC FIBROSIS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; TRIAZOLES;

EID: 84926336309     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0035-1546750     Document Type: Article

References (155)

1. Barker A. F. Bronchiectasis. N Engl J Med: 2002; 346 18 1383 1393
2. O'Donnell A. E. Bronchiectasis. Chest: 2008; 134 4 815 823
3. Naidich D. P., McCauley D. I., Khouri N. F., Stitik F. P., Siegelman S. S. Computed tomography of bronchiectasis. J Comput Assist Tomogr: 1982; 6 3 437 444
4. Bonavita J., Naidich D. P. Imaging of bronchiectasis. Clin Chest Med: 2012; 33 2 233 248
5. Hill A. T., Pasteur M., Cornford C., Welham S., Bilton D. Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J: 2011; 20 2 135 140
6. King P., Holdsworth S., Freezer N., Holmes P. Bronchiectasis. Intern Med J: 2006; 36 11 729 737
7. McShane P. J., Naureckas E. T., Tino G., Strek M. E. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med: 2013; 188 6 647 656
8. Seitz A. E., Olivier K. N., Adjemian J., Holland S. M., Prevots R. Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000 to 2007. Chest: 2012; 142 2 432 439
9. Pasteur M. C., Helliwell S. M., Houghton S. J., et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med: 2000; 162 (4, Pt 1): 1277 1284
10. Cole P. J. Inflammation: a two-edged sword-the model of bronchiectasis. Eur J Respir Dis Suppl: 1986; 147 6 15
11. Whitters D., Stockley R. Immunity and bacterial colonisation in bronchiectasis. Thorax: 2012; 67 11 1006 1013
12. Bilton D. Update on non-cystic fibrosis bronchiectasis. Curr Opin Pulm Med: 2008; 14 6 595 599
13. Wickremasinghe M., Ozerovitch L. J., Davies G., et al. Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax: 2005; 60 12 1045 1051
14. Knutsen A. P., Bush R. K., Demain J. G., et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol: 2012; 129 2 280 291, quiz 292-293
15. Tunney M. M., Einarsson G. G., Wei L., et al. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med: 2013; 187 10 1118 1126
16. Rogers G. B., van der Gast C. J., Cuthbertson L., et al. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax: 2013; 68 8 731 737
17. Agarwal R., Chakrabarti A., Shah A., et al. ABPA complicating asthma ISHAM working group. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy: 2013; 43 8 850 873
18. Delhaes L., Monchy S., Fréalle E., et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management. PLoS ONE: 2012; 7 4 e36313
19. Mounier J., Gouëllo A., Keravec M., et al. Use of denaturing high-performance liquid chromatography (DHPLC) to characterize the bacterial and fungal airway microbiota of cystic fibrosis patients. J Microbiol: 2014; 52 4 307 314
20. Harrison M. J., Twomey K. B., McCarthy Y., et al. The role of second-generation sequencing in describing the fungal microbiota in the adult cystic fibrosis airway and its correlation with clinical phenotype. [Abstract] J Cyst Fibros: 2013; 12 (Suppl): S16
21. Moss R. B. Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis. Eur Respir J: 2014; 43 5 1487 1500
22. Kwon-Chung K. J., Sugui J. A. Aspergillus fumigatus -what makes the species a ubiquitous human fungal pathogen? PLoS Pathog: 2013; 9 12 e1003743
23. Chotirmall S. H., Mirkovic B., Lavelle G. M., McElvaney N. G. Immunoevasive Aspergillus virulence factors. Mycopathologia: 2014; 178 5-6 363 370
24. Chowdhary A., Agarwal K., Kathuria S., Gaur S. N., Randhawa H. S., Meis J. F. Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview. Crit Rev Microbiol: 2014; 40 1 30 48
25. Ishiguro T., Takayanagi N., Kagiyama N., Shimizu Y., Yanagisawa T., Sugita Y. Clinical characteristics of biopsy-proven allergic bronchopulmonary mycosis: variety in causative fungi and laboratory findings. Intern Med: 2014; 53 13 1407 1411
26. Matsuse H., Tsuchida T., Fukahori S., et al. Dissociation between sensitizing and colonizing fungi in patients with allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol: 2013; 111 3 190 193
27. Tashiro T., Izumikawa K., Tashiro M., et al. Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward. Med Mycol: 2011; 49 6 581 587
28. Shah A., Maurya V., Panjabi C., Khanna P. Allergic bronchopulmonary aspergillosis without clinical asthma caused by Aspergillus niger. Allergy: 2004; 59 2 236 237
29. Al-Mobeireek A. F., Al-Hedaithy S. S., Alasali K., Al-Majed S., Joharjy I.; El-Rab MOGAD. Allergic bronchopulmonary mycosis in patients with asthma: period prevalence at a university hospital in Saudi Arabia. Respir Med: 2001; 95 5 341 347
30. Hoshino H., Tagaki S., Kon H., et al. Allergic bronchopulmonary aspergillosis due to Aspergillus niger without bronchial asthma. Respiration: 1999; 66 4 369 372
31. Shimada T., Matsumura K. [A case of probable allergic bronchopulmonary aspergillosis due to Aspergillus niger]. Nihon Kyobu Shikkan Gakkai Zasshi: 1995; 33 3 336 341
32. Sandhu R. S., Mehta S. K., Khan Z. U., Singh M. M. Role of Aspergillus and Candida species in allergic bronchopulmonary mycoses. A comparative study. Scand J Respir Dis: 1979; 60 5 235 242
33. Oshima M., Soda H., Oda H., Watanabe A. A case of allergic bronchopulmonary aspergillosis caused by Aspergillus terreus [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi: 1997; 35 12 1418 1424
34. Nakahara Y., Katoh O., Yamada H., Sumida I., Hanada M. Allergic bronchopulmonary aspergillosis caused by Aspergillus terreus presenting lobar collapse. Intern Med: 1992; 31 1 140 142
35. Vincken W., Schandevul W., Roels P. Allergic bronchopulmonary aspergillosis caused by Aspergillus terreus. Am Rev Respir Dis: 1983; 127 3 388 389
36. Yamamoto K., Abe M., Inoue Y., Yokoyama A., Kohno N., Hiwada K. Development of infection with Aspergillus flavus in woman being treated for allergic pulmonary Aspergillosis caused by Aspergillus fumigatus [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi: 1995; 33 10 1099 1104
37. Novey H. S., Wells I. D. Allergic bronchopulmonary aspergillosis caused by Aspergillus ochraceus. Am J Clin Pathol: 1978; 70 5 840 843
38. Poole C. J., Wong M. Allergic bronchopulmonary aspergillosis in garden waste (compost) collectors-occupational implications. Occup Med (Lond): 2013; 63 7 517 519
39. Kurosawa M., Kobayashi S., Yanagihara Y., Shida T. A case of occupational allergic bronchopulmonary aspergillosis unique to Japan. Br J Clin Pract: 1990; 44 11 482 489
40. Akiyama K., Takizawa H., Suzuki M., Miyachi S., Ichinohe M., Yanagihara Y. Allergic bronchopulmonary aspergillosis due to Aspergillus oryzae. Chest: 1987; 91 2 285 286
41. Kino T., Chihara J., Mitsuyasu K., et al. A case of allergic bronchopulmonary aspergillosis caused by Aspergillus oryzae which is used for brewing bean paste (miso) and soy sauce (shoyu) (author's transl) [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi: 1982; 20 4 467 475
42. Boucher R. C. Bronchiectasis: a continuum of ion transport dysfunction or multiple hits? Am J Respir Crit Care Med: 2010; 181 10 1017 1019
43. Bienvenu T., Sermet-Gaudelus I., Burgel P. R., et al. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med: 2010; 181 10 1078 1084
44. Gonska T., Choi P., Stephenson A., et al. Role of cystic fibrosis transmembrane conductance regulator in patients with chronic sinopulmonary disease. Chest: 2012; 142 4 996 1004
45. Chaudhary N., Datta K., Askin F. B., Staab J. F., Marr K. A. Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation. Am J Respir Crit Care Med: 2012; 185 3 301 310
46. Allard J. B., Poynter M. E., Marr K. A., Cohn L., Rincon M., Whittaker L. A. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J Immunol: 2006; 177 8 5186 5194
47. Müller C., Braag S. A., Herlihy J. D., et al. Enhanced IgE allergic response to Aspergillus fumigatus in CFTR-/- mice. Lab Invest: 2006; 86 2 130 140
48. Mueller C., Braag S. A., Keeler A., Hodges C., Drumm M., Flotte T. R. Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. Am J Respir Cell Mol Biol: 2011; 44 6 922 929
49. Rapaka R. R., Kolls J. K. Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. Med Mycol: 2009; 47 01 S331 S337
50. Eickmeier O., Rieber N., Eckrich J., Hector A., Graeppler-Mainka U., Hartl D. Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease. Curr Pharm Des: 2013; 19 20 3669 3678
51. Chotirmall S. H., Al-Alawi M., Mirkovic B., et al. Aspergillus-associated airway disease, inflammation, and the innate immune response. Biomed Res Int: 2013; 2013 723129
52. Sabino R., Ferreira J. A., Moss R. B., et al. Molecular epidemiology of Aspergillus collected from cystic fibrosis patients. J Cyst Fibros: 2014;; doi: 10.1016/j.jcf.2014.10.005 [E-pub ahead of print]
53. Baxter C. G., Dunn G., Jones A. M., et al. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol: 2013; 132 3 560 566.e10
54. Armstead J., Morris J., Denning D. W. Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis. PLoS ONE: 2014; 9 6 e98502
55. Nicolai T., Arleth S., Spaeth A., Bertele-Harms R. M., Harms H. K. Correlation of IgE antibody titer to Aspergillus fumigatus with decreased lung function in cystic fibrosis. Pediatr Pulmonol: 1990; 8 1 12 15
56. Wojnarowski C., Eichler I., Gartner C., et al. Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. Am J Respir Crit Care Med: 1997; 155 6 1902 1907
57. Kanthan S. K., Bush A., Kemp M., Buchdahl R. Factors effecting impact of Aspergillus fumigatus sensitization in cystic fibrosis. Pediatr Pulmonol: 2007; 42 9 785 793
58. Fillaux J., Brémont F., Murris M., et al. Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients. Scand J Infect Dis: 2012; 44 11 842 847
59. Baxter C. G., Moore C. B., Jones A. M., Webb A. K., Denning D. W. IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis. Chest: 2013; 143 5 1351 1357
60. Peetermans M., Goeminne P., De Boeck C., Dupont L. J. IgE sensitization to Aspergillus fumigatus is not a bystander phenomenon in cystic fibrosis lung disease. Chest: 2014; 146 3 e99 e100
61. Kraemer R., Deloséa N., Ballinari P., Gallati S., Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med: 2006; 174 11 1211 1220
62. Chotirmall S. H., McElvaney N. G. Fungi in the cystic fibrosis lung: bystanders or pathogens? Int J Biochem Cell Biol: 2014; 52 161 173
63. Parize P., Billaud S., Bienvenu A. L., et al. Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis. J Cyst Fibros: 2014; 13 6 667 673
64. Kondori N., Lindblad A., Welinder-Olsson C., Wennerås C., Gilljam M. Development of IgG antibodies to Exophiala dermatitidis is associated with inflammatory responses in patients with cystic fibrosis. J Cyst Fibros: 2014; 13 4 391 399
65. Barenfanger J., Ramirez F., Tewari R. P., Eagleton L. Pulmonary phaeohyphomycosis in a patient with hemoptysis. Chest: 1989; 95 5 1158 1160
66. Mukaino T., Koga T., Oshita Y., Narita Y., Obata S., Aizawa H. Exophiala dermatitidis infection in non-cystic fibrosis bronchiectasis. Respir Med: 2006; 100 11 2069 2071
67. Ozawa Y., Suda T., Kaida Y., et al. [A case of bronchial infection of Wangiella dermatitidis]. Nihon Kokyuki Gakkai Zasshi: 2007; 45 11 907 911
68. Murayama T., Amitani R., Tsuyuguchi K., et al. Polypoid bronchial lesions due to Scedosporium apiospermum in a patient with Mycobacterium avium complex pulmonary disease. Eur Respir J: 1998; 12 3 745 747
69. Greig J. R., Khan M. A., Hopkinson N. S., Marshall B. G., Wilson P. O., Rahman S. U. Pulmonary infection with Scedosporium prolificans in an immunocompetent individual. J Infect: 2001; 43 1 15 17
70. Stick S. M., Brennan S., Murray C., et al. Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF). Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr: 2009; 155 5 623 8.e1
71. Sly P. D., Brennan S., Gangell C., et al. Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST-CF). Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med: 2009; 180 2 146 152
72. Mott L. S., Park J., Murray C. P., et al. AREST CF. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax: 2012; 67 6 509 516
73. Sly P. D., Gangell C. L., Chen L., et al. AREST CF Investigators. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med: 2013; 368 21 1963 1970
74. Goffard A., Lambert V., Salleron J., et al. Virus and cystic fibrosis: rhinoviruses are associated with exacerbations in adult patients. J Clin Virol: 2014; 60 2 147 153
75. LiPuma J. J. Expanding our understanding of respiratory microbiota in cystic fibrosis. Ann Am Thorac Soc: 2014; 11 7 1084 1085
76. Ramsey K. A., Ranganathan S., Park J., et al. AREST CF. Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis. Am J Respir Crit Care Med: 2014; 190 10 1111 1116
77. McMahon M. A., Chotirmall S. H., McCullagh B., Branagan P., McElvaney N. G., Logan P. M. Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population. Eur J Radiol: 2012; 81 3 e197 e202
78. Reihill J. A., Moore J. E., Elborn J. S., Ennis M. Effect of Aspergillus fumigatus and Candida albicans on pro-inflammatory response in cystic fibrosis epithelium. J Cyst Fibros: 2011; 10 6 401 406
79. Kapur N., Grimwood K., Masters I. B., Morris P. S., Chang A. B. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis. Pediatr Pulmonol: 2012; 47 3 300 307
80. Ward S., Heyneman L., Lee M. J., Leung A. N., Hansell D. M., Müller N. L. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol: 1999; 173 4 937 942
81. Angus R. M., Davies M. L., Cowan M. D., McSharry C., Thomson N. C. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax: 1994; 49 6 586 589
82. Eaton T., Garrett J., Milne D., Frankel A., Wells A. U. Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. Chest: 2000; 118 1 66 72
83. Fairs A., Agbetile J., Hargadon B., et al. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med: 2010; 182 11 1362 1368
84. Menzies D., Holmes L., McCumesky G., Prys-Picard C., Niven R. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy: 2011; 66 5 679 685
85. Denning D. W., O'Driscoll B. R., Hogaboam C. M., Bowyer P., Niven R. M. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J: 2006; 27 3 615 626
86. Agbetile J., Fairs A., Desai D., et al. Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. Clin Exp Allergy: 2012; 42 5 782 791
87. Heaney L. G., Conway E., Kelly C., et al. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax: 2003; 58 7 561 566
88. Reese T. A., Liang H. E., Tager A. M., et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature: 2007; 447 7140 92 96
89. Van Dyken S. J., Garcia D., Porter P., et al. Fungal chitin from asthma-associated home environments induces eosinophilic lung infiltration. J Immunol: 2011; 187 5 2261 2267
90. Neveu W. A., Bernardo E., Allard J. L., et al. Fungal allergen β-glucans trigger p38 mitogen-activated protein kinase-mediated IL-6 translation in lung epithelial cells. Am J Respir Cell Mol Biol: 2011; 45 6 1133 1141
91. Amitani R., Taylor G., Elezis E. N., et al. Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun: 1995; 63 9 3266 3271
92. Carrion SdeJ, Leal S. M. Jr, Ghannoum M. A., Aimanianda V., Latgé J. P., Pearlman E. The RodA hydrophobin on Aspergillus fumigatus spores masks dectin-1- and dectin-2-dependent responses and enhances fungal survival in vivo. J Immunol: 2013; 191 5 2581 2588
93. Oosthuizen J. L., Gomez P., Ruan J., et al. Dual organism transcriptomics of airway epithelial cells interacting with conidia of Aspergillus fumigatus. PLoS ONE: 2011; 6 5 e20527
94. Grimm M. J., Vethanayagam R. R., Almyroudis N. G., et al. Monocyte- and macrophage-targeted NADPH oxidase mediates antifungal host defense and regulation of acute inflammation in mice. J Immunol: 2013; 190 8 4175 4184
95. Park S. J., Mehrad B. Innate immunity to Aspergillus species. Clin Microbiol Rev: 2009; 22 4 535 551
96. Brown G. D. Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol: 2011; 29 1 21
97. Underhill D. M., Iliev I. D. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol: 2014; 14 6 405 416
98. Kreindler J. L., Steele C., Nguyen N., et al. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest: 2010; 120 9 3242 3254
99. Becker K. L., Gresnigt M. S., Smeekens S. P., et al. Pattern recognition pathways leading to a Th2 cytokine bias in ABPA patients. Clin Exp Allergy: 2015; 45 2 423 437
100. Romani L. Immunity to fungal infections. Nat Rev Immunol: 2011; 11 4 275 288
101. Wark P. A., Saltos N., Simpson J., Slater S., Hensley M. J., Gibson P. G. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J: 2000; 16 6 1095 1101
102. Gibson P. G., Wark P. A., Simpson J. L., et al. Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis. Eur Respir J: 2003; 21 4 582 588
103. Fei M., Bhatia S., Oriss T. B., et al. TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection. Proc Natl Acad Sci U S A: 2011; 108 13 5360 5365
104. Porter P. C., Lim D. J., Maskatia Z. K., et al. Airway surface mycosis in chronic TH2-associated airway disease. J Allergy Clin Immunol: 2014; 134 2 325 331
105. Homma T., Bhushan B., Kato A., et al. Aspergillus fumigatus may promote Th2 activation by suppression of interferon signaling. [abstract] J Allergy Clin Immunol: 2014; 133 (2, Suppl): AB136
106. Hartl D., Buckland K. F., Hogaboam C. M. Chemokines in allergic aspergillosis-from animal models to human lung diseases. Inflamm Allergy Drug Targets: 2006; 5 4 219 228
107. Kheradmand F., Kiss A., Xu J., Lee S. H., Kolattukudy P. E., Corry D. B. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol: 2002; 169 10 5904 5911
108. Reed C. E., Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol: 2004; 114 5 997 1008, quiz 1009
109. Porter P., Susarla S. C., Polikepahad S., et al. Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi. Mucosal Immunol: 2009; 2 6 504 517
110. Porter P. C., Yang T., Luong A., et al. Proteinases as molecular adjuvants in allergic airway disease. Biochim Biophys Acta: 2011; 1810 11 1059 1065
111. Namvar S., Warn P., Farnell E., Bromley M., Bowyer P., Herrick S. Aspergillus fumigatus proteases, Asp f 5 and Asp f 13, are essential for airway inflammation and remodelling in a murine inhalation model. Clin Exp Allergy: 2014;. doi: 10.1111/cea. 12426 [e-Pub ahead of print]
112. Agarwal R., Khan A., Gupta D., Aggarwal A. N., Saxena A. K., Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS ONE: 2010; 5 12 e15346
113. Agarwal R., Khan A., Garg M., Aggarwal A. N., Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol: 2012; 4 4 141 150
114. Oguma T., Asano K., Tomomatsu K., et al. Induction of mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells. J Immunol: 2011; 187 2 999 1005
115. Fahy J. V., Schuster A., Ueki I., Boushey H. A., Nadel J. A. Mucus hypersecretion in bronchiectasis. The role of neutrophil proteases. Am Rev Respir Dis: 1992; 146 6 1430 1433
116. Denning D. W., Pleuvry A., Cole D. C. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol: 2013; 51 4 361 370
117. Leclair L. W., Hogan D. A. Mixed bacterial-fungal infections in the CF respiratory tract. Med Mycol: 2010; 48 01 S125 S132
118. Tomlinson J. R., Sahn S. A. Aspergilloma in sarcoid and tuberculosis. Chest: 1987; 92 3 505 508
119. Denning D. W., Pleuvry A., Cole D. C. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ: 2011; 89 12 864 872
120. Dhooria S., Kumar P., Saikia B., et al. Prevalence of Aspergillus sensitisation in pulmonary tuberculosis-related fibrocavitary disease. Int J Tuberc Lung Dis: 2014; 18 7 850 855
121. Moore E. H. Atypical mycobacterial infection in the lung: CT appearance. Radiology: 1993; 187 3 777 782
122. Kunst H., Wickremasinghe M., Wells A., Wilson R. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir J: 2006; 28 2 352 357
123. Levy I., Grisaru-Soen G., Lerner-Geva L., et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis: 2008; 14 3 378 384
124. Mussaffi H., Rivlin J., Shalit I., Ephros M., Blau H. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J: 2005; 25 2 324 328
125. Harris J. K., Zemanick E. T. Microbes in bronchiectasis: the forest or the trees? Am J Respir Crit Care Med: 2013; 187 10 1044 1045
126. Greene R. The pulmonary aspergilloses: three distinct entities or a spectrum of disease. Radiology: 1981; 140 2 527 530
127. Buckingham S. J., Hansell D. M. Aspergillus in the lung: diverse and coincident forms. Eur Radiol: 2003; 13 8 1786 1800
128. Chrdle A., Mustakim S., Bright-Thomas R. J., Baxter C. G., Felton T., Denning D. W. Aspergillus bronchitis without significant immunocompromise. Ann N Y Acad Sci: 2012; 1272 73 85
129. Shah A., Panjabi C. Allergic aspergillosis of the respiratory tract. Eur Respir Rev: 2014; 23 131 8 29
130. Kosmidis C., Denning D. W. The clinical spectrum of pulmonary aspergillosis. Thorax: 2014;. doi: 10.1136/thoraxjnl-2014-206291 [E-pub ahead of print]
131. Patterson R., Greenberger P. A., Halwig J. M., Liotta J. L., Roberts M. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med: 1986; 146 5 916 918
132. Greenberger P. A., Miller T. P., Roberts M., Smith L. L. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy: 1993; 70 4 333 338
133. Agarwal R., Garg M., Aggarwal A. N., Saikia B., Gupta D., Chakrabarti A. Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes. Respir Med: 2012; 106 7 942 947
134. Moss R. B. Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis. Curr Opin Pulm Med: 2010; 16 6 598 603
135. Agarwal R., Aggarwal A. N., Garg M., Saikia B., Gupta D., Chakrabarti A. Allergic bronchopulmonary aspergillosis with aspergilloma: an immunologically severe disease with poor outcome. Mycopathologia: 2012; 174 3 193 201
136. Chung Y., Kraut J. R., Stone A. M., Valaitis J. Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosis. Pediatr Pulmonol: 1994; 17 2 131 134
137. Ganassini A., Cazzadori A. Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis. Respir Med: 1995; 89 2 143 145
138. Massam J., Bitnun A., Solomon M., et al. Invasive aspergillosis in cystic fibrosis: a fatal case in an adolescent and review of the literature. Pediatr Infect Dis J: 2011; 30 2 178 180
139. Mosquera R. A., Estrada L., Clements R. M., Jon C. K. Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis. BMJ Case Rep: 2013; 2013
140. Stevens D. A., Moss R. B., Kurup V. P., et al. Participants in the Cystic Fibrosis Foundation Consensus Conference. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis: 2003; 37 03 S225 S264
141. Agarwal R., Maskey D., Aggarwal A. N., et al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS ONE: 2013; 8 4 e61105
142. Agarwal R., Aggarwal A. N., Garg M., Saikia B., Chakrabarti A. Cut-off values of serum IgE (total and A. fumigatus -specific) and eosinophil count in differentiating allergic bronchopulmonary aspergillosis from asthma. Mycoses: 2014; 57 11 659 663
143. Gernez Y., Dunn C. E., Everson C., et al. Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by Aspergillus allergens. J Cyst Fibros: 2012; 11 6 502 510
144. Moss R. B. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis. Ann N Y Acad Sci: 2012; 1272 49 57
145. Wong R., Wong M., Robinson P. D., Fitzgerald D. A. Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis. Paediatr Respir Rev: 2013; 14 1 22 24
146. Homma T., Kurokawa M., Matsukura S., Yamaguchi M., Adachi M. Anti-IgE therapy for allergic bronchopulmonary aspergillosis. J Microbiol Immunol Infect: 2013;. doi: 10.1016/j.jmii.2013.10.003 [E-pub ahead of print]
147. Tanou K., Zintzaras E., Kaditis A. G. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence. Pediatr Pulmonol: 2014; 49 5 503 507
148. Zicari A. M., Celani C., De Castro G., Valerio De Biase R., Duse M. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis. Eur Rev Med Pharmacol Sci: 2014; 18 13 1839 1841
149. Lehmann S., Pfannenstiel C., Friedrichs F., Kröger K., Wagner N., Tenbrock K. Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Ther Adv Respir Dis: 2014; 8 5 141 149
150. Moss R. B. Critique of trials in allergic bronchopulmonary aspergilllosis and fungal allergy. Med Mycol: 2006; 44 01 S269 S272
151. Moss R. B. Management of allergic aspergillosis. Curr Fungal Infect Reports: 2008; 2 2 87 93
152. Moreira A. S., Silva D., Ferreira A. R., Delgado L. Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review. Clin Exp Allergy: 2014; 44 10 1210 1227
153. Chishimba L., Langridge P., Powell G., Niven R. M., Denning D. W. Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). J Asthma: 2014; 23 1 7
154. Sehgal I. S., Agarwal R. Role of inhaled amphotericin in allergic bronchopulmonary aspergillosis. J Postgrad Med: 2014; 60 1 41 45
155. Denning D. W., Pashley C., Hartl D., et al. Fungal allergy in asthma-state of the art and research needs. Clin Transl Allergy: 2014; 4 14